Transjugularis intrahepaticus portosystemas shunt a portalis hipertonia gyógyításában by Lázár, István László
Theses of Ph.D. dissertation
TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN 
THE TREATMENT OF PORTAL HYPERTENSION.
Dr. Lázár István




The mortality of chronic liver diseases increased to more than twice in Hungary in the last 
couple of years. More than 8000 peoples die in every year due to the symptoms of portal 
hipertension1 like variceal bleeding, hepatorenal syndrome or spontaneous bacterial 
peritonitis. Less life threatening but also severe sequels are refractory ascites and/or 
hydrothorax, hepatic encephalopathy and hepatopulmonary syndrome2. The decrease of the 
hepatocytes and the vascular failure of the liver induce a chain of deterioration regardless of 
the cause of the cirrhosis.  The symptoms of the patients are independently divided between 
the vascular and parenchymal impairment of the liver. Insufficient hepatic function is 
exclusively treatable with liver transplantation meanwhile in the treatment of portal 
hypertension we have multiple alternatives,3 like selective beta-blockers surgical portocaval
shunt procedures and transjugular intrahepatic portosystemic shunt (TIPS).
TIPS was introduced in the nineties and up to now more than 130000 TIPS were performed 
all over the world4. This procedure extremely efficiently decreases portal pressure and 
bleeding varices can also be treated at the same time.
Procedural morbidity is lower compared to surgical shunts. TIPS is more efficient to prevent 
variceal bleeding compared to endoscopic methods5 and to treat refractory ascites compared 
to diuretics combined with paracentesis6,7. TIPS presents a significant procedural challenge 
and needs technical skills and experiences, as well as good collaboration with internists and 
anesthesists and a well equipped angio suit. Since 1999 TIPS is successfully performed in 
Miskolc and the results are extensively published and presented both in abroad and 
HungaryS3,4,7,9,12.
Purposes
1. To figure out the place of TIPS in the treatment of patients with portal hypertension and to 
show its advantages compared to endoscopic and surgical methods. 
2. To present the technical and clinical results of TIPS in large and consecutive patient cohort. 
3. To describe the rare procedural complication like the dissection of the portal vein firstly 
published by us and other technical difficulties and complications of TIPS.
4. To present the results with rare indications like TIPS in children, TIPS in Budd-Chiari sy. 
or the treatment of occlusion of the portal vein. All these were firstly performed in 
Hungary. 
5. To describe our technical inventions performed during TIPS revisions. 
6. To remind on the radiation exposure of the patients and the staff during TIPS.
7. To present our unique Hungarian 4-year-experiences with stent-grafts for TIPS. 
Patients and methods
The first TIPS was performed in September 1999 at the Borsod County Teaching Hospital in 
Miskolc. Indications for TIPS were raised by gastroenterologists and transplant surgeons. 
60% of our patients were admitted from outside of the recruitment area of the hospital. TIPS 
was performed in 114 patients. The gender of patients was: 66 male, 48 female (58 and 42 %). 
Age distribution of the patients: between 10-34 years - 7 patients, 36-44 years - 17 patients, 
45-54 years - 44 patients, 55-64 years - 34 patients, >65 years – 12 patients. 
Distribution of the patients according to the Child-Pugh score: 
A: 24 patients (21%)  B: 62 patients (54,4%)   C: 28 patients (24,6%).
Child-Pugh classification is based on 5 parameters (serum total bilirubin, total protein, INR, 
the severity of ascites and hepatic encephalopathy) each of them rated 1-3 points. Scores are 
divided like Child-A 5-6 points Child-B 7-9 points and Child-C >10 points.
149 TIPS procedure (including revisions) were performed. 
Indications of TIPS procedures:
Refractory ascites /hydrothorax 58 patients 36 %
Recurrent variceal bleeding 47 patients 29,2 %
Acute variceal bleeding 9 patients 5,6 %
Thrombosis of the portal vein 4 patients 2,5 %
Budd-Chiari syndrome 1 patients 0,6 %
TIPS revisions 42 procedures in 31 patients 26,1 %
Primary TIPS were performed according to the description of American and German
interventionists15,31. Invasive pressure measurements were done in 72 patients TIPS (63,2 %). 
Systemic venous pressure was measured in the right atrium. Portal pressures (all in Hgmm) 
were determined in the splenic vein and the portosystemic pressure gradients were calculated. 
In more then 90% of the cases TIPS-200 (Rösch-Uchida) set produced by Cook, in less than 
10% other sets (TJL-100 - Colapinto) were used. 25 patients underwent TIPS with Viatorr 
stent-grafts. Wallstents were deployed in 97 patients. Nitinol or other peripheral stents were 
implanted in 8 cases.
Patients were followed up every 3 months in the first year after TIPS, than every 6 months.   
They underwent clinical tests and Doppler ultrasonography. 
Total time of fluoroscopy was documented in 69 TIPS, meanwhile DAP (dose area product) 
datas were worked up in 48 procedures.
Results and practical use of the results 
1. TIPS compared to endoscopic and surgical methods in the treatment of portal hypertension
 Despite their proven results in abroad, TIPS was not recognized in Hungary until the 
end of nineties. Firstly, Péter M. presented cases with short description of the 
method32 but wide recognition of the technique had to wait for our published results 
and the proof of clinical success in large patient cohortS3. Due to our results TIPS 
became the second line therapy of patients with portal hypertension in northern 
Hungary.
 The majority of Hungarian patients undergo TIPS in our cath-lab. I assisted or trained 
interventionists to perform the procedure in other three centers. 
 TIPS served as a bridge to successful liver transplantation in 5 of our patients. In other 
4 patients TIPS made such an important clinical improvement that these patients did 
not need transplantation, and could be cancelled from waiting list. 
 TIPS became the treatment of choice in patients with acute subcardial variceal 
bleeding or those who had recurrent variceal bleeding after more then 3 sclerotherapy. 
All the acutely treated patients improved clinically. This needs to be emphasized, as 
we lost 5 patients in the waiting list for TIPS!
 TIPS also became the method of choice in the treatment of patients with refractory 
ascites for 4-9 months despite maximal diuretic therapy. Our results are so convincing 
that 50,9% of TIPS patients were admitted with this indication. 
2. The success rates of TIPS
 Intrahepatic punction was successful in 97,4%. TIPS could be performed in 95,7. (The 
difference is coming from the cases when extrahepatic portal vein occlusion was 
recognized only after the punction of the portal vein). These are the best Hungarian
results and also fulfill north-American requirements. 
 We achieved the demanded portosystemic pressure gradient in 94,7% of patients. The 
mean gradient decreased from 19,6 to 8,9 mmHg. 
 Clinical success was achieved in 88,6% of patients.
 We added 4 new indications for TIPS in Hungary: Budd-Chiari syndrome, TIPS in a 
child, subacute portal vein thrombosis, TIPS in transplanted liver.
3. Complications of TIPS
 Our rate of serious complications is within the ranges of recommendation according to 
the Society of Cardiovascular and Interventional Radiology of North America33 (1. 
table):
Early complications SCVIR recommended (%) Own results (%) 
    Intraperitoneal bleeding 7 4,4
    Gallbladder punction 2 1,7
    Stent malposition 2 1,7
    Haemobilia 2 0,8
    Radiation skin injury 0,1 0
    Infection 2 2,6
    Hepatic artery injury 1-5 0,8
    Haemolysis 10 -
   Jugular hematome 5 3,5
   Contrast nephropathy 5 2,6
    Worsened encephalopathy 20-30 17
    Pulmonary edema 1 0
    Procedural mortality <1 1,7
Late complications
    Persisting ascites 10-30 10,5
    Recurrent variceal bleeding 15-25 7
    TIPS stenosis (with bare stents) 50 (in the first year) 23,7
1. table: TIPS complications as recommended and our results 
 We firstly ever published a procedural complication in the literature. We observed the 
dissection of the portal vein in 1% in our practice and published three casesS7. 
4.  TIPS procedures firstly ever performed in Hungary
 The first child who underwent TIPS was a 10 years old boy with liver and renal failure 
of unknown etiology. He presented gastro-esophageal variceal bleedings and waited 
for transplantation. I performed TIPS for him in acute settings. At that time living 
donor transplantation was not yet performed in Hungary, but TIPS successfully served 
as a bridge for transplantation Beside the size of kid (he weighted 28 kg) technical 
difficulties came from the preazotemic state of the patient. We injected only 30 ml of 
iodinated contrast medium during the procedure. No more bleeding occurred until the 
transplantation of both the liver and the kidneys 5 months later.
 I performed TIPS for the first time in Hungary in patient with Budd-Chiari syndrome.
The patient presented with severe vascular failure of the liver and waited for 
transplantation. As there was no patent hepatic vein I started the punction from the 
intrahepatic portion of the inferior vena cava. The one year ultrasonographic control of 
the patient showed normal flow through the shunt. He has no symptoms at all and is 
not a transplant candidate anymore. 
 The third newly performed procedure was a TIPS in a 41-year-old male with 
thrombosis of the portal vein due to protein C deficiency. He presented with refractory 
ascites. During the procedure we also had to perform the angioplasty of the 
recanalized spleno-mesenteric venous confluent in order to normalize the 
portosystemic pressure gradient. TIPS was technically successful but unfortunately the 
patient died 6 weeks later due to progressive parenchymal liver failure. 
5.  My technical inventions performed during TIPS revisions
 To decrease the symptoms of worsened hepatic encephalopathy due to TIPS I used a 
non-published method of narrowing the shunt. In two cases a self-expandable stent 
was deployed through the non-covered portion of the previously implanted stent-graft. 
Distal portion of this narrowing stent was placed outside of the previous. The proximal 
part of the stent remained inside and finally showed an hour-glass shape. So, the stent 
was perpendicularly deployed and decreased the inflow of the TIPS and consequently
increased the portosystemic pressure gradient. 
 The other invention helped to recanalize an occluded shunt. For anatomic reasons 
there was no chance to get into the lumen of the TIPS from the proximal part. Finally I 
made a punction with a liver biopsy needle through the sidewall of the TIPS and got 
into the portal vein. The new TIPS performed through the mashes of the previous stent 
kept normal flow for two years. The patient is free of symptoms and is not a candidate 
for liver transplantation anymore.
6. The radiation exposure of the patients and the staff during TIPS
 The mean DAP was 6181 (546-17999) Gy/cm2, the mean skin dose was found to be
583 (66-2151) mGy. Total fluoroscopy mean time was 24,5 minutes (6,8-83 min.). 
According to these datas TIPS is one of the procedures with the highest radiation 
exposure for the patients. However, we did not experience skin erythema or other skin 
reaction. 
 We regularly use all of the available radiation protection devices and none of the film 
dosimetric studies of the staff showed significant elevation of irradiation. My own 
body exposure datas from the last years are:
2002: 0,23 mSv   2003: 0,14 mSv   2004: 0,18 mSv   2005: 0,25 mSv, 
2006: under noticeable (These datas were accumulated during all of angiographic 
workload – more than 1000/year - not only TIPS.)
7. Experiences with stent-grafts for TIPS
 We used stent-grafts for TIPS in a uniquely large number of cases in Hungary, which 
is also in international comparison a significant number. The reason was to improve 
long-term results and to prevent or treat procedural complications. Since July 2002 
TIPS was performed in 80 patients. 25 of them (31,25%) underwent TIPS or revision 
with PTFE-covered stent-graft.
Our indications for the use of stent-graft were:
1. Longer life expectancy according to liver function (Child-Pugh A,B)
2. Younger age - 44,7 years (33-59) – mean age of our other patients 52,7 years
3. Complicated procedure makes early shunt failure likely (i.e. biliary punction) 
4. Budd-Chiary sy. 
5. Recurrent revisions
 Only two of the 25 implanted grafts failed. One patient developed portal thrombosis 5
months later so the lack of inflow was the cause of TIPS failure. The other patient 
developed hepatocellular carcinoma and subsequent portal vein thrombosis 4 months 
after TIPS. For this reason we did not try to recanalize the shunt. 
 The rate of encephalopathy which necessitated narrowing of the shunt was not higher 
(8%) than in TIPS cases with bare stents. 
 Revisions were indicated far less frequently than in TIPS with bare stents. They were 
necessary only in false positive follow up diagnostic results. (One early control when 
ultrasound could not penetrate the grafts due to captured air bubbles. The other was 
due to a misinterpreted CT in an inexperienced institution.) 
 Two stent-graft patients were transplanted since. Both of them developed progressive
liver failure (primary biliary cirrhosis and persisting B-virus hepatitis). The 
transplantation was not complicated by the TIPS stent-graft in any of them34. 
Consequently, it seems to be clear that using stent-graft for proper indications can 
significantly decrease the expenses of health care system and increase life-chances of 
cirrhotic patients. 
Conclusions
1. The place of TIPS in the treatment of patients with portal hypertension.
 TIPS is proved to be the most effective method to decrease portal hypertension35,36. It 
is more invasive and more expensive than endoscopic methods, therefore only in case 
of clinical failure of the latter is indicated37,38. 
 The advantage of TIPS is being more efficient to prevent recurrent variceal bleeding 
than endoscopic ligation or sclerotherapy or non-selective ß-blockers like 
proplanolol37,38. The likelihood of recurrent variceal bleeding is found to be 19% after 
TIPS while 47% with endoscopic treatment5. Recent improvements result in less than
30% recurrence rate but using stent-grafts for TIPS can improve the results even more, 
below 10%22-24. Nevertheless, TIPS with bare stent do not improve the survival of 
patients39. The preliminary results of the use of stent-grafts seem to strongly suggest 
that this is going to be changed. 
 In the treatment of refractory ascites TIPS has 79% efficacy after 6 months, while 
repeated paracentesis only 24%40. TIPS procedural morbidity is so much lower than 
the morbidity of surgical shunts (i.e. Denver) that the latter are less and less practiced. 
2. Technical results of TIPS
 TIPS procedure has lot of technical difficulties. For the expected results we have to (a) 
carefully select patients (b) carry out the procedure in a controlled and standardized 
way (c) to monitorize patients during TIPS and the next 6 hours.
 The interventionist who has carried out the TIPS procedure has to follow the clinical 
course of the patients as well. Technical and clinical success, as well as the rate of 
complications have to be continuously checked. Significant prolongation of hospital 
stay, the need of intensive care, definitive failure of any organ or death in 30 day has 
to be concerned as major complication. They altogether must not exceed 5%. 
Expected rates of success33: 
Technical success: (Patent intrahepatic shunt)  95%
Hemodynamical success:
(Expected decrease of the portosystemic pressure gradient) 95%
Clinical success: (Significant decrease of symptoms.) 90%
3.  Intraoperative complications of TIPS
We have to face numerous difficulties during this challenging procedure41.
 During jugular vein punction nerve injury, pneumothorax, neck hematoma, 
pseuodaneurysm of the carotid arteries can occur. Most of them can be prevented with 
ultrasonographic guidance, placing the patient into Trendelenburg position and asking 
him to perform Valsalva maneuver. 
 During catheterization of the hepatic vein arrhythmia (guidewire or introducer in the 
right atrium) can occur. Guidewire can buckle in the atrium and devices intended to 
push through can even perforate the heart.  
 Left liver lobe or segment I. hypertrophy can raise anatomic difficulties. Hepatic veins 
run almost horizontal in cases of tense ascites as well. Left jugular vein approach and 
paracentesis can ease these situations. 
 Localization of portal branch as a target of intrahepatic punction can be made by 
iodinated contrast material or CO2 injection into the wedged hepatic vein catheter. 
During this step of the procedure subcapsular haematoma or even severe liver 
laceration can occur. The bleeding site has to be promptly embolized and stent-graft 
deployment can also decrease the bleeding.
 The most critical moment of TIPS creation is intrahepatic punction. We can observe 
extrahepatic punction, biliary punction, extrahepatic portal punction or hepatic artery 
punction. The most important is to recognize them and alert the anesthesiologist. At 
the same time we have different tools to deal with the complication (embolization, 
balloon tamponade, stent-graft deployment, blood transfusion). The most dangerous 
complication is the punction of an extrahepatic portal branch because the next step is 
the dilatation of the punctured branch. If it is not tamponnated by the liver this carries 
a real risk of bleeding to death. The extrahepatic punction itself can be clinically 
silent if treated with stent-graft placement42.
 We published firstly ever in the literature the rare complication of portal vein 
dissection during TIPSS7. Our explanation is that portal pressure in our patients was 
measured 32-44 mmHg instead of the physiologic 10-12 mmHg and this can produce 
significant change in the wall of large veins, like portal vein. This extreme pressure 
makes the thin internal elastic membrane surrounded by smooth muscular fibers less
compliant because of fibrosis. According to our experiences it may develop – similarly 
to the arteries – a dissection along this layer during punction or more likely due to the 
direct perpendicular force applied on the guidewire at the end of the needle. Dissection 
can result in exactly the same consequences like in the arteries. We have, for instance, 
a well documented case of pseudoaneurysm formation.
 During stent placement migration or malposition can occur. It is very important to let 
the proximal part of the stent free for a subsequent catheterization because the need for 
TIPS revision is quite high later on. We have to keep in mind also an eventual liver 
transplantation. That is why the stent must not encroach on the lumen of inferior vena 
cava and must not reach the confluent of superior mesenteric vein and splenic vein in 
order not to interfere with a future clamping by transplantation. Using stent-grafts we 
have to make correct measurements not to obstacle the blood flow with the covered 
part of the graft in the main portal branch or in the inferior vena cava. 
 Dilating a TIPS stent: overdilation should be avoided not to provoke hepatic 
encephalopathy. Wallstent has known ability to selfdilate over 24 hours. Using stent-
grafts we don’t have to count on late restenosis. There will not be anything to decrease 
the flow through an over dilated shunt. 
 Variceal embolization is routinely part of TIPS in case of the treatment of acutely 
bleeding patients. Embolizing agents can be moved to pulmonary circulation through 
the varices41. When using acrilates, solidified glue may attach to the end of the
delivery catheter and by pulling back the catheter, the glue can be detached and 
obstacles splenic vein or even the TIPS channel.
4. TIPS procedures firstly ever performed in Hungary
 TIPS can be safely performed even in high-risk situations in the hand of experienced 
interventionist, who treats a reasonable number of patients yearly. The angio suit has 
to possess all the materials potentially needed and the operator has to check up the 
results time to time for quality improvements. It is clearly demonstrated with the case 
of a 19-year-old girl who presented with Budd-Chiary syndrome a couple of years 
ago. She could not be transplanted soon after and 3 months later bled to death from her 
subcardial varices. 3 years later – as we possessed stent-graft and had more 
experiences – a successful TIPS was performed in the same clinical scenario. This 
fortunate patient is not even a transplant candidate anymore48.
5. My technical inventions performed during TIPS revisions
I firstly described two technical points make TIPS revisions possible or more successful in 
difficult situations. Both of them have proved midterm results already. 
 Inner PTFE covering of stent-grafts result in an extremely smooth surface. Thus, 
stents used for narrowing to reverse hepatic encephalopathy can easily migrate. Stent 
migration towards the heart is practically impossible with my method. Beside, there is 
a potential disadvantage because theoretically the blood which is flowing through the 
mash of the stent may hemolyse. Erythrocytes already damaged by the impaired liver 
function can be crushed at the metal mash of the stent and finally eliminated by the 
spleen49. This type of hemolysis is not severe and self-limited in most of the cases. 
 My second invention for revision of a thrombosed TIPS has obviously alternatives. 
The parallel TIPS between the left hepatic vein and the left portal branch is a known 
tool as a supplement for the previously performed TIPS if the function of the former 
was not sufficient to decrease the portosystemic pressure gradient50 We also had such 
a case performed to replace the right sided TIPS which had been occluded several 
times due to unfavorable anatomy. Despite this successful case – having known the 
technical difficulties of that – I am convinced that it is reasonable to try firstly my new 
method to regain the patency of the thrombosed TIPS. Procedural risk seems to be 
lower and at the same time we can reserve the chance for the patient to undergo an 
eventual left sided TIPS if it was going to be inevitable.  
6. The radiation exposure of the patients and the staff during TIPS
 There are few datas in the literature concerning radiation doses of patients and staff 
during TIPS. Our measures for patients proved no higher entry skin dose than 3  Gy 
(limit of depilation). The results of an American study covering 135 TIPS procedure 
found 38,7 min. average fluoroscopy time and 2039 mGy cumulative skin dose51. 
Comparing our result (24,5 min. fluoroscopy and 583 mGy) with these there is no 
reason to be unsatisfied.
  
7. Experiences with stent-grafts for TIPS
 TIPS performed with bare stents during the first 10 years after the introduction of the 
procedure resulted in disappointment with the long-term results7,29,35. Reintervention 
rate and additional cost with that was very high44. The average one-year patency 
without revision was found to be no more than 69%53. Stent-grafts raised that number 
up to 85-90% and the secondary one-year patency from 85% up to 98%22-24, 54. Only 
the bile impermeable ePTFE-covered grafts achieved such a favorable result. Others, 
like PET-covered grafts developed not specifically for TIPS did not improve the 
patency rate54. 
 Control ultrasonography after TIPS with stent-graft is indicated only in case of 
recurrent clinical signs or no more frequently than every 6 months according to my 
results. 
 The rate of worsened hepatic encephalopathy was not higher with stent-grafts than 
with bare stents. It can be explained by the fact that grafts are dilated to a smaller 
diameter having known that they are significantly less prone to in-stent restenosis. 
 Our 90% primary one-year patency rate with grafts suggests that stent-grafts 
significantly decrease the reintervention rate and the cost of the treatment. At the same 
time long term success makes gastroenterologist and transplant surgeons more 
confident with this method. 
We can conclude, that TIPS is safe method to treat portal hypertension with lower morbidity 
and higher efficacy than surgical or endoscopic methods. Proper indications, experience-
based patient choice, technical developments like stent-grafts improved long-term patency 
and widened the acceptance of TIPS. We have to prove the economical efficacy and make the 
method better known and available all over in Hungary. These are the key points to better 
treat hundreds of patients with impaired liver function and make their life expectancy longer. 
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